NYSE:IPV InterPrivate Acquisition (IPV) Stock Price, News & Analysis → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free IPV Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$2.91▼$3.0950-Day Range$9.59▼$16.1652-Week Range$9.15▼$21.83Volume216,656 shsAverage Volume1.40 million shsMarket Capitalization$91.30 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsSocial MediaStock AnalysisCompetitorsSocial Media Get InterPrivate Acquisition alerts: Email Address Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy About InterPrivate AcquisitionInterprivate Acquisition Corp. does not have significant operations. It focuses on the merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The company was founded in 2019 and is based in New York, New York.Read More Ad TranzactWhat is Medicare Supplement Insurance?Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. Learn More Here IPV Stock News HeadlinesMarch 4, 2024 | markets.businessinsider.comInterPrivate Acquisition earnings: here's what to expectDecember 27, 2023 | uk.investing.comInterPrivate III Financial Partners Inc UnitApril 26, 2024 | Behind the Markets (Ad)The World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!November 7, 2023 | markets.businessinsider.comHere's what Wall Street expects from InterPrivate Acquisition's earningsOctober 10, 2023 | thestreet.comInterPrivate IV InfraTech Partners Inc. WarrantAugust 31, 2023 | investing.comInterPrivate III Financial Partners Inc (IPVF)August 7, 2023 | markets.businessinsider.comIPv4.Global Hits $1 Billion Milestone for IPv4 SalesMay 10, 2023 | markets.businessinsider.comInterPrivate Acquisition earnings preview: what Wall Street is expectingApril 26, 2024 | Behind the Markets (Ad)The World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!May 5, 2023 | finance.yahoo.comInterPrivate IV InfraTech Partners Inc. Announces it Will Redeem its Public Shares and Will Not Consummate an Initial Business CombinationMay 4, 2023 | benzinga.comInterPrivate III Financial Partners Inc. Announces Extension of Deadline to Complete Initial Business CombinationMarch 31, 2023 | morningstar.comInterPrivate III Financial Partners Inc Ordinary Shares - Class A IPVF Stock QuoteJanuary 31, 2023 | businesswire.comBronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Aeva, Inc. (AEVA) InvestigationDecember 15, 2022 | benzinga.comInterPrivate III Financial Partners Inc. Announces Amendment and Supplements to it Definitive Proxy StatementDecember 15, 2022 | benzinga.comInterprivate IV Infratech Partners Inc. Announces Amendment and Supplements to its Definitive Proxy StatementNovember 17, 2022 | marketwatch.comInterPrivate II Schedules Getaround Deal Vote, Plans Bonus SharesMay 11, 2022 | news.yahoo.comCarsharing marketplace Getaround to go public via $1.2 billion SPAC dealMay 10, 2022 | finance.yahoo.comCar-Sharing Startup Getaround Nears InterPrivate SPAC MergerApril 8, 2022 | investing.comIPV_u Historical DataSee More Headlines Receive IPV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InterPrivate Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry Holding & Other Investment Offices Sub-IndustryN/A Current SymbolNYSE:IPV CUSIPN/A CIKN/A Webipvspac.com Phone212 647 0166FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio1.91 Quick Ratio1.91 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares31,056,000Free FloatN/AMarket Cap$91.30 million OptionableNot Optionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Ahmed Mohamed Fattouh (Age 47)CEO & Chairman Mr. Brandon Cowles Bentley (Age 46)Gen. Counsel & Director Mr. Alan Pinto (Age 49)Sr. VP Mr. Brian Q. Pham (Age 33)Sr. VP This page (NYSE:IPV) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldTrump is sounding the alarmPreserve GoldFed launches fourth dollar overhaulStansberry ResearchBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InterPrivate Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
